Search
for
Sort by
Research 691–720 of 1000+
- Treatment of pediatric alopecia areata: A systematic review
- Update on hidradenitis suppurativa: connecting the tracts
- Risk of Polycystic Ovary Syndrome in Women Exposed to Fine Air Pollutants and Acidic Gases: A Nationwide Cohort Analysis
- Under Development JAK Inhibitors for Dermatologic Diseases
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- “A thing of beauty is a joy forever”. Plants and plant-based preparations for facial care in Suriname
- Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long‐Term Multicentre Real‐World Study
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Clinical Applications of Extracellular Vesicles: Promises and Pitfalls
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis
- Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
- Light exposure and its applications in human health
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- 1,314
- Proceedings of the Ninth World Congress for Hair Research (2015)
- ZALCITABINE
- Vitiligo—Current Treatment Options and Future Perspectives
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- The patient journey in prurigo nodularis: what lies ahead
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis
- Current Advanced Therapies Based on Human Mesenchymal Stem Cells for Skin Diseases
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis